(secondQuint)iFuse Implant System Minimally Invasive Arthrodesis.

 This study is a multicenter randomized controlled, post-market clinical follow-up clinical trial of the iFuse Implant System for SI joint fusion vs.

 conservative management.

 Subjects assigned to conservative management may cross over to iFuse after a minimum of 6 months of conservative treatment.

 Conservative management does not include interventional procedures such as prolotherapy, steroid injections and/or RF ablation.

.

 iFuse Implant System Minimally Invasive Arthrodesis@highlight

The purpose of this study is to compare outcomes when patients with chronic sacroiliac joint pain undergo either SI joint fusion with the iFuse Implant System or undergo conservative management of the SI joint